Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations

Area of Science:

• Gastroenterology
• Infectious Diseases
• Public Health

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, presents unique challenges for patients with Inflammatory Bowel Disease (IBD).
• Existing research on IBD and COVID-19 is fragmented across multiple scientific publications.
• A comprehensive overview is needed to guide clinical practice and patient management.

Purpose of the Study:

• To synthesize and summarize the current body of knowledge regarding IBD patients and COVID-19.
• To consolidate information on infection risk, clinical outcomes, and management strategies for IBD patients during the pandemic.
• To provide a unified resource addressing vaccination, endoscopy, and patient well-being in the context of SARS-CoV-2.

Main Methods:

• This study conducted a literature review, synthesizing existing research.
• Key issues were identified and compiled from numerous scientific articles.
• The synthesis focused on specific aspects of IBD patient care during the pandemic.

Main Results:

• Information on SARS-CoV-2 infection risk and outcomes in IBD patients was collated.
• Guidance on IBD treatment and endoscopy procedures during the pandemic was summarized.
• Data on vaccination efficacy and patient perceptions of well-being were integrated.

Conclusions:

• A comprehensive understanding of IBD patient issues during the COVID-19 pandemic is crucial for effective healthcare.
• This review consolidates scattered knowledge, offering a valuable resource for clinicians and researchers.
• Addressing infection risk, treatment modifications, and patient well-being is essential for managing IBD in the SARS-CoV-2 era.